Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

Maximilian Stahl, Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami Komrokji, Mina L. Xu, Omar Abdel-Wahab, Justin Taylor, David P. Steensma, Daniel T. Starczynowski, Mikkael A. Sekeres, Guillermo Sanz, David A. Sallman, Gail J. Roboz, Uwe Platzbecker, Mrinal M. Patnaik, Eric Padron, Olatoyosi Odenike, Stephen D. Nimer, Aziz NazhaRavi Majeti, Sanam Loghavi, Richard F. Little, Alan F. List, Tae Kon Kim, Christopher S. Hourigan, Robert P. Hasserjian, Stephanie Halene, Elizabeth A. Griffiths, Steven D. Gore, Peter Greenberg, Maria E. Figueroa, Pierre Fenaux, Fabio Efficace, Amy E. DeZern, Naval G. Daver, Jane E. Churpek, Hetty E. Carraway, Rena Buckstein, Andrew M. Brunner, Jacqueline Boultwood, Uma Borate, Rafael Bejar, John M. Bennett, Andrew H. Wei, Valeria Santini, Michael R. Savona, Amer M. Zeidan

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)'. Together they form a unique fingerprint.

Medicine & Life Sciences